Back to results
US 9,173,920 B2Granted
Methods of treating muscular wasting diseases using NF-KB activation inhibitors
AssigneeTheralogics, Inc.
InventorsDenis C. Guttridge, Albert S. Baldwin
Life of this patent
Estimating the term…
Abstract
Methods for treating muscular wasting diseases such as Duchenne muscular dystrophy are disclosed. Specifically, the methods include administering to a subject in need of treatment for a muscular wasting disease, an NF-κB activation inhibitor capable of blocking the activation of NF-κB.
Claims9
A method of treating Duchenne muscular dystrophy in a subject, the method comprising administering to the subject an NF-κB activation inhibitor comprising:
- a polypeptide having the amino acid sequence of SEQ ID NO:
- 1 or SEQ ID NO:
- 17.
Dependencies are inferred from the claim text.